ICM
CCEL icon

ISZO Capital Management’s Cryo-Cell International CCEL Stock Holding History

ISZO Capital Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-195,031
Closed -$825K – 11
2022
Q4 		$825K Sell
195,031
-83,842
-30% -$401K 11.03% 5
2022
Q3 		$1.7M Sell
278,873
-74,337
-21% -$458K 2.92% 5
2022
Q2 		$2.08M Sell
353,210
-3,897
-1% -$24.9K 3.27% 5
2022
Q1 		$2.73M Sell
357,107
-125,824
-26% -$1.16M 3.23% 5
2021
Q4 		$5.6M Sell
482,931
-13,572
-3% -$169K 2.95% 6
2021
Q3 		$6.01M Buy
+496,503
New +$6.12M 2.65% 6

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ISZO Capital Management's CCEL Position: Q1 2023 in Review

ISZO Capital Management sold out of Cryo-Cell International (CCEL) in Q1 2023, closing a stake of 195,031 shares — an estimated $825K sold.

ISZO Capital Management first reported a position in CCEL in Q3 2021 and held it in 6 quarters. The position peaked at $6.01M in Q3 2021. 12 funds tracked by Wall St. Rank hold CCEL as of Q1 2023.

  • ISZO Capital Management reported no remaining Cryo-Cell International position as of Q1 2023 after selling out during the quarter.
  • ISZO Capital Management sold 195,031 Cryo-Cell International shares in Q1 2023, an estimated $825K.
  • ISZO Capital Management first reported a position in Cryo-Cell International in Q3 2021 and held it in 6 quarters.
  • ISZO Capital Management's Cryo-Cell International position peaked at $6.01M in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2023.

Based on ISZO Capital Management's 13F filing for Q1 2023, filed 15 May 2023.